UMass Medical School

Following the unexpected death of Dr. Michael Green, UMass Chan has selected two faculty members to fill the void left by the former professor and vice provost for strategic research initiatives.

Hiring remains a challenge at companies still focused on growth and recruitment, in part due to the high cost of living in Massachusetts.

UMass Chan Medical School is consolidating its workforce at MassBiologics, its Boston-based biologics and vaccine manufacturing arm. The affected positions will be eliminated in 60 days.

UMass Memorial Health has appointed Dr. Lynda Young as board chair and Elvira Guardiola as vice chair of the board of trustees. Young is the first woman to be chair, and Guardiola is the first woman and the first Latina to be vice chair.

A legal battle is being fought between UMass Chan Medical School and UMass Memorial Health over millions of dollars from UMass Memorial’s 2019 sale of its stake in Shields Health Solutions to Walgreens Boots Alliance, Inc. 

Webster developer Galaxy Life Sciences purchased the final three lots at The Reactory biomanufacturing campus on Belmont Street in Worcester for $4 million on Thursday.

Dr. Michael Green, vice provost for strategic research initiatives, and professor and chair of molecular, cell and cancer biology at UMass Chan Medical School in Worcester, has died.

UMass Chan Medical School in Worcester has licensed its bioinformatics data processing and analysis technology, called Foundry, to Via Scientific Inc., a Cambridge technology company.

Commonwealth Medicine, the consulting arm of UMass Chan Medical School in Worcester, announced Tuesday its new name.

UMass Chan Medical School in Worcester will receive a public assistance grant of $4.3 million to reimburse the school for COVID-19 tests administered between May 2020 and December 2021.